SPL.AX: Summary for STARPHARMA FPO - Yahoo Finance

Australia Markets closed

Starpharma Holdings Limited (SPL.AX)


ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.740.00 (0.00%)
At close: 4:10PM AEST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous close0.74
Open0.75
Bid0.73 x
Ask0.74 x
Day's range0.74 - 0.76
52-week range0.59 - 0.88
Volume1,408,082
Avg. volume319,429
Market cap272.76M
Beta0.51
PE ratio (TTM)-11.75
EPS (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire17 days ago

    Ansell Launches VivaGel® Condom in Canada

    MELBOURNE, Australia--(BUSINESSWIRE)-- Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) is pleased to announce the VivaGel ® condom has been launched in Canada by Ansell (ASX:ANN) under the LifeStyles ® ...

  • Business Wire4 months ago

    VivaGel® BV granted QIDP and Fast Track designation by US FDA

    MELBOURNE, Australia--(BUSINESSWIRE)-- Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced it has been granted Qualified Infectious Disease Product (QIDP) and Fast Track designation for VivaGel® BV by the US Food and Drug Administration (FDA). QIDP and Fast Track designations were granted independently for both the VivaGel® BV treatment and prevention indications for bacterial vaginosis (BV). This positive development recognises the high unmet medical need in the management of BV and the potential of VivaGel® BV to address that need for both treatment and prevention of recurrent BV, markets estimated to be worth in excess of US$1 billion globally.

  • noodls4 months ago

    Starpharma receives $3.5M R&D tax incentive refund

    Starpharma receives $3.5M R&D tax incentive refund Melbourne, Australia; 22 December 2016: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced it has received the anticipated $3.5M of R&D ...